Surgery Partners, Inc. (SGRY) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Surgery Partners, Inc. (SGRY) stock forecast summary
On Oct. 14, 2026, SGRY is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 4004 stocks scored that day.
Surgery Partners, Inc. is a small-cap company with a market capitalization of $1.90B. It ranks number 4 by market capitalization among the 6 Services-General Medical & Surgical Hospitals, NEC issuers in our coverage with a current forecast.
A per-ticker accuracy statistic for SGRY is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.2%, buy ≥ +0.5%, sell < -0.6%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, SGRY included.
Follow SGRY freeSGRY price chart and AI forecast
How SGRY ranks among 4004 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Surgery Partners, Inc. (SGRY) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-General Medical & Surgical Hospitals, NEC peers listed below that report each metric.
Valuation & Market
| Metric | SGRY | Rank |
|---|---|---|
| Market Cap | $1.90B | 4/6 |
| P/B Ratio | 1.14x | – |
| EPS | $-0.71 | – |
| Book Value/Share | $12.76 | – |
| Revenue/Share | $25.71 | – |
| FCF/Share | $1.43 | – |
Profitability & Margins
| Metric | SGRY | Rank |
|---|---|---|
| ROE | -5.3% | – |
| ROA | -1.1% | 6/6 |
| ROIC | 5.1% | – |
| Operating Margin | 11.4% | – |
| Net Margin | -2.6% | 6/6 |
| EBT Margin | 11.3% | 3/6 |
| Tax Rate | 5.4% | – |
Financial Health
| Metric | SGRY | Rank |
|---|---|---|
| Current Ratio | 1.95x | 2/6 |
| Quick Ratio | 1.78x | – |
| D/E Ratio | 2.96x | – |
| Financial Leverage | 4.82x | – |
| Interest Coverage | 0.4x | – |
| Working Capital | $548M | 4/6 |
Cash Flow
| Metric | SGRY | Rank |
|---|---|---|
| Operating Cash Flow | $258M | 5/6 |
| Free Cash Flow | $188M | 4/5 |
| Capital Spending | -$70M | 1/5 |
| OCF Growth YoY | -2.2% | 4/6 |
| FCF Growth YoY | 7.0% | 3/5 |
| FCF/Sales | 5.6% | 3/5 |
| CapEx/Sales | 2.1% | 5/5 |
Operational Efficiency
| Metric | SGRY | Rank |
|---|---|---|
| Asset Turnover | 0.42x | 6/6 |
| Receivables Turnover | 5.5x | 6/6 |
| Fixed Assets Turnover | 8.2x | 1/6 |
| Days Sales Outstanding | 67 days | 1/6 |
Income Statement
| Metric | SGRY | Rank |
|---|---|---|
| Total Revenue | $3.37B | 6/6 |
| Operating Income | $383M | – |
| Net Income | -$88M | 6/6 |
Dividend & Shareholder Information
| Metric | SGRY | Rank |
|---|---|---|
| Shares Outstanding | 131M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $1.13B | 14.0% of assets |
| Cash & Short-term Investments | $217M | 2.7% of assets |
| Accounts Receivable | $617M | 7.7% of assets |
| Inventory | $99M | 1.2% of assets |
| Total Liabilities | $4.95B | 61.5% of assets |
| Short-term Debt | $403M | 5.0% of assets |
SGRY quarterly financials and insider trading
Surgery Partners, Inc. (SGRY) industry peers
Companies classified under the same SEC industry code as Surgery Partners, Inc. (Services-General Medical & Surgical Hospitals, NEC): 6 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up freeWhere SGRY sits on the market map
Surgery Partners, Inc. (SGRY) stock news
Loading...
Surgery Partners, Inc. (SGRY) stock forecast FAQ
What is the Surgery Partners, Inc. (SGRY) stock forecast?
On Oct. 14, 2026, SGRY is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 4004 stocks scored that day.
How accurate are Surgery Partners, Inc. stock predictions?
A per-ticker accuracy statistic for SGRY is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Surgery Partners, Inc. forecasts updated?
Surgery Partners, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are Surgery Partners, Inc.'s industry peers?
6 issuers in our coverage, SGRY included, share the SEC industry code Services-General Medical & Surgical Hospitals, NEC. The largest are: Hca Healthcare, Inc. (HCA), Tenet Healthcare Corp (THC), Universal Health Services Inc (UHS), Ardent Health, Inc. (ARDT), Community Health Systems Inc (CYH).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.